Patrick Acer,Patrick Andersen,Robbie Barbero,Stephanie Barksdale,Sophia Bellakbira,Dalton Bunde,Ross Dunlap,James Erickson,Daniel Goldfarb,Tara Jones-Roe,Michael Kilroy,Hien Le,Ben Lepene,Emily Milich,Ayan Mohamed,Sayed Mosavi,Denton Munns,Jared Obermeyer,Anurag Patnaik,Ganit Pricer,Marion Reven,Dalaun Richardson,Chamodya Ruhunusiri,Saswata Sahoo,Lauren P. Saunders,Olivia Swahn,Kalpita Vengurlekar,David White,Jean Lozach,Aouda Patricia Flores-Baffi,Fletcher Easton,Maya Dahlke,Andrea Fang,David Cibin,Tim Wesselman,Orlando Sablon,Marlene Wolfe,Penbgo Liu,Stephen Hilton,Yuke Wang,Christine L. Moe,Siya Kashwala,Erica Camarato,Shreya Shrestha,Regan Wied,Adelaide Roguet,Kayley Janssen,Dagmara Antkiewicz,Ian Bradley,Sydney Gallo,Yinyin Ye,Sarah Kane,Jim Huang,Johannah Gillespie,Andrew Jones,Mayumi E. Pascual,Dolores Sanchez Gonzalez,Michael Secreto,Rachel Poretsky,Sarah Owens,Stephanie M. Greenwald,Rose Wilton,Elizabeth Donahue

Abstract:Wastewater testing has emerged as an effective tool for monitoring levels of SARS-CoV-2 infection in sewered communities. As of July 2024, PCR-based methods continue to be the most widely used methods in wastewater surveillance. Data from PCR-based wastewater testing is usually available to public health authorities in near real time, typically within 5 to 7 days after waste enters the sewer. Unfortunately, while these methods can accurately detect and quantify SARS-CoV-2, they are not usually used to differentiate between the multitude of variants, including variants that are classified as Variants of High Consequence (VOHC) and Variants of Concern (VOC). Currently, to identify these variants, the extracted nucleic acids must be analyzed using resource-intensive sequencing-based methods. Moreover, not every lab has access to sequencing technology, so availability of equipment and expertise is also a roadblock besides These costly and time-consuming sequencing methods, while informative, diminish some of the early warning benefits provided by wastewater surveillance. Moreover, not every lab has access to sequencing technology, creating additional barriers due to the availability of equipment and expertise. In response to these analytical shortcomings, we developed and assessed an alternative approach for variant monitoring in wastewater using customizable dPCR-based genotyping assays. This approach is an expansion from a previously described method for analyzing clinical samples utilizing customizable qPCR-based genotyping. Relative to sequencing, this approach is cost-effective, fast, and easily implemented. We combined the dPCR-based wastewater genotyping approach along with the well-established Nanotrap® Particles virus concentration method as part of a wastewater processing protocol to perform SARS-CoV-2 genotyping in five wastewater testing labs across multiple regions in the United States. The results for the wastewater genotyping approach are displayed on a public-facing dashboard alongside clinical genotyping results and GISAID data (see https://tracker.rosalind.bio). Despite conducting genotyping on fewer wastewater samples than clinical samples, our approach effectively detected signals of emerging variants and trends in SARS-CoV-2 variants within the community, similar to clinical analyses. For instance, in Georgia, the rapid rise and dominance of the Unknown and BA.2.86*/JN* variants in early 2024 were consistently observed in wastewater samples and closely matched trends in the GISAID clinical sequencing database. Similarly, the EG.5* and FL* variants showed elevated signals in wastewater before clinical detection, highlighting the early warning potential of wastewater testing. Detailed analysis of multiple datasets from various states revealed consistency in the rise and fall of variants across wastewater genotyping, clinical genotyping, and GISAID data. This consistency demonstrates that the prevalence of variants in wastewater closely matches that in clinical settings, underscoring the capability of wastewater-based surveillance to provide extended monitoring of circulating variants, often preceding clinical detections by several weeks. We further assessed the wastewater genotyping approach by calculating positive percent agreement for detection of four variants (JN, EG.5, FL, and XBB) between the genotyping results and whole genome sequencing results for a set of 129 matched samples that were analyzed using both methods. The agreement ranged between 54% agreement for FL to 97% agreement for JN, with an average of 76% agreement across all samples for all four variants. Additionally, we estimate that collecting and analyzing data using the dPCR genotyping method is significantly less expensive and time-consuming compared to next-generation sequencing. Labs that outsource next-generation sequencing face much higher costs and longer delays. Transitioning to multiplex dPCR for variant detection could further reduce both cost and turnaround time. Finally, we discuss the challenges and lessons learned in the development, validation, and implementation of dPCR-based wastewater genotyping. These findings support the use of wastewater-based surveillance as a complementary approach to clinical surveillance, offering a broader and more inclusive picture of variant prevalence and transmission in the community.

NCBI submission protocol for SARS-CoV-2 wastewater data: SRA, BioSample, and BioProject v1

SARS-CoV-2 NCBI submission protocol: SRA, BioSample, and BioProject v2

SARS-CoV-2 NCBI submission protocol: SRA, BioSample, and BioProject v3

SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA's GenomeTrakr network

SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA’s GenomeTrakr network

Harnessing methods, data analysis, and near-real-time wastewater monitoring for enhanced public health response using high throughput sequencing.

Optimised protocol for monitoring SARS-CoV-2 in wastewater using reverse complement PCR-based whole-genome sequencing

Validating and optimizing the method for molecular detection and quantification of SARS-CoV-2 in wastewater

Expanding a Wastewater-Based Surveillance Methodology for DNA Isolation from a Workflow Optimized for SARS-CoV-2 RNA Quantification

Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing

High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples

Surveillance of SARS-CoV-2 RNA in wastewater: Methods optimisation and quality control are crucial for generating reliable public health information

Long-term monitoring of SARS-CoV-2 load and variant composition at a large metropolitan wastewater treatment plant using a simple two-step direct capture RNA extraction, droplet digital PCR, and targeted mutation assays

Wastewater-Based Protocols for SARS-CoV-2: Insights into Virus Concentration, Extraction and Quantitation Methods from Two Years of Public Health Surveillance

Quantification of SARS-CoV-2 and cross-assembly phage (crAssphage) from wastewater to monitor coronavirus transmission within communities

Lessons learned from SARS-CoV-2 measurements in wastewater

Novel dPCR-Based Approach for SARS-CoV-2 Variant Detection and Monitoring in Wastewater: A Multi-State Comparison with Clinical Genotyping and GISAID Sequencing Data

Monitoring SARS-CoV-2 Populations in Wastewater by Amplicon Sequencing and Using the Novel Program SAM Refiner

Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission

SARS-CoV-2 Wastewater Genomic Surveillance: Approaches, Challenges, and Opportunities

Minimizing errors in RT-PCR detection and quantification of SARS-CoV-2 RNA for wastewater surveillance